600 related articles for article (PubMed ID: 23765504)
1. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation.
Stone D; Byrne T; Pershad A
Catheter Cardiovasc Interv; 2015 Jul; 86(1):121-7. PubMed ID: 23765504
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience.
Bartus K; Han FT; Bednarek J; Myc J; Kapelak B; Sadowski J; Lelakowski J; Bartus S; Yakubov SJ; Lee RJ
J Am Coll Cardiol; 2013 Jul; 62(2):108-118. PubMed ID: 23062528
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.
Massumi A; Chelu MG; Nazeri A; May SA; Afshar-Kharaghan H; Saeed M; Razavi M; Rasekh A
Am J Cardiol; 2013 Mar; 111(6):869-73. PubMed ID: 23312129
[TBL] [Abstract][Full Text] [Related]
4. The role of multimodality imaging in percutaneous left atrial appendage suture ligation with the LARIAT device.
Laura DM; Chinitz LA; Aizer A; Holmes DS; Benenstein R; Freedberg RS; Kim EE; Saric M
J Am Soc Echocardiogr; 2014 Jul; 27(7):699-708. PubMed ID: 24874974
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of closed-chest ligation of the left atrial appendage in humans.
Bartus K; Bednarek J; Myc J; Kapelak B; Sadowski J; Lelakowski J; Yakubov SJ; Lee RJ
Heart Rhythm; 2011 Feb; 8(2):188-93. PubMed ID: 21050893
[TBL] [Abstract][Full Text] [Related]
6. Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results of a multicenter study.
Mohanty S; Gianni C; Trivedi C; Gadiyaram V; Della Rocca DG; MacDonald B; Horton R; Al-Ahmad A; Gibson DN; Price M; Krumerman AK; Palma EC; Di Biase L; Lakkireddy D; Natale A
Heart Rhythm; 2020 Feb; 17(2):175-181. PubMed ID: 31400519
[TBL] [Abstract][Full Text] [Related]
7. Left atrial appendage ligation with the next generation LARIAT(+) suture delivery device: Early clinical experience.
Bartus K; Gafoor S; Tschopp D; Foran JP; Tilz R; Wong T; Lakkireddy D; Sievert H; Lee RJ
Int J Cardiol; 2016 Jul; 215():244-7. PubMed ID: 27128539
[TBL] [Abstract][Full Text] [Related]
8. First in vivo evaluation of a flexible self-apposing left atrial appendage closure device in the canine model.
Cheng Y; Conditt G; Yi G; Tellez A; Corcoran M; Rousselle S; Kaluza GL; Granada JF
Catheter Cardiovasc Interv; 2015 Jul; 86(1):173-81. PubMed ID: 24130158
[TBL] [Abstract][Full Text] [Related]
9. Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience.
Fink T; Schlüter M; Tilz RR; Heeger CH; Lemes C; Maurer T; Reissmann B; Rottner L; Santoro F; Mathew S; Rillig A; Ouyang F; Kuck KH; Metzner A
Clin Res Cardiol; 2018 Dec; 107(12):1139-1147. PubMed ID: 29881879
[TBL] [Abstract][Full Text] [Related]
10. Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device.
Gianni C; Di Biase L; Trivedi C; Mohanty S; Gökoğlan Y; Güneş MF; Bai R; Al-Ahmad A; Burkhardt JD; Horton RP; Krumerman AK; Palma EC; Valderrábano M; Gibson D; Price MJ; Natale A
JACC Cardiovasc Interv; 2016 May; 9(10):1051-7. PubMed ID: 27198686
[TBL] [Abstract][Full Text] [Related]
11. Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application.
Pillai AM; Kanmanthareddy A; Earnest M; Reddy M; Ferrell R; Nath J; Pillarisetti J; Vallakati A; Lakkireddy D
Heart Rhythm; 2014 Nov; 11(11):1877-83. PubMed ID: 24993460
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
[TBL] [Abstract][Full Text] [Related]
13. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
[TBL] [Abstract][Full Text] [Related]
14. A collective European experience with left atrial appendage suture ligation using the LARIAT+ device.
Tilz RR; Fink T; Bartus K; Wong T; Vogler J; Nentwich K; Panniker S; Fang Q; Piorkowski C; Liosis S; Gaspar T; Sawan N; Metzner A; Nietlispach F; Maisano F; Lee RJ; Foran JP; Ouyang F; Sievert H; Deneke T; Kuck KH
Europace; 2020 Jun; 22(6):924-931. PubMed ID: 32044994
[TBL] [Abstract][Full Text] [Related]
15. Extending percutaneous left atrial appendage closure indications using the AMPLATZER™ Cardiac Plug device in patients with persistent left atrial appendage thrombus: The thrombus trapping technique.
Jalal Z; Iriart X; Dinet ML; Selly JB; Tafer N; Renou P; Sibon I; Thambo JB
Arch Cardiovasc Dis; 2016 Dec; 109(12):659-666. PubMed ID: 27402154
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes from real-world experience of left atrial appendage exclusion with LARIAT device.
Parikh V; Bartus K; Litwinowicz R; Turagam MK; Sadowski J; Kapelak B; Bartus M; Podolec J; Brzezinski M; Musat D; Rasekh A; Mittal S; Cheng J; Badhwar N; Lee R; Lakkireddy D
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2849-2857. PubMed ID: 31596044
[TBL] [Abstract][Full Text] [Related]
17. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
Ramlawi B; Abu Saleh WK; Edgerton J
Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
[TBL] [Abstract][Full Text] [Related]
18. [Percutaneous closure of the left atrial appendage: a new option for the prevention of thromboembolic stroke].
Oto A; Aytemir K; Okutucu S; Kaya EB; Sahiner L; Sabanov C; Evranos B
Turk Kardiyol Dern Ars; 2011 Dec; 39(8):668-74. PubMed ID: 22257805
[TBL] [Abstract][Full Text] [Related]
19. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device.
Miller MA; Gangireddy SR; Doshi SK; Aryana A; Koruth JS; Sennhauser S; d'Avila A; Dukkipati SR; Neuzil P; Reddy VY
Heart Rhythm; 2014 Nov; 11(11):1853-9. PubMed ID: 25068574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
